Bioventus Inc.BVSNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank58
3Y CAGR-20.2%
5Y CAGR+1.6%
Year-over-Year Change
Research and development spending
3Y CAGR
-20.2%/yr
vs +31.0%/yr prior
5Y CAGR
+1.6%/yr
Recent deceleration
Acceleration
-51.2pp
Decelerating
Percentile
P58
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $12.11M | -11.2% |
| 2024 | $13.64M | +1.4% |
| 2023 | $13.45M | -43.6% |
| 2022 | $23.85M | +25.3% |
| 2021 | $19.04M | +70.0% |
| 2020 | $11.20M | +1.3% |
| 2019 | $11.05M | +36.6% |
| 2018 | $8.10M | -0.0% |
| 2017 | $8.10M | +2.5% |
| 2016 | $7.90M | - |